Detalhe da pesquisa
1.
Molecular, clinical and therapeutic determinants of outcome in NPM1 mutated AML.
Blood
; 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38691678
2.
A randomized comparison of CPX-351 and FLAG-Ida in adverse karyotype AML and high-risk MDS: the UK NCRI AML19 trial.
Blood Adv
; 7(16): 4539-4549, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37171402
3.
Two subsets of human marginal zone B cells resolved by global analysis of lymphoid tissues and blood.
Sci Immunol
; 7(69): eabm9060, 2022 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35302862
4.
A Randomized Comparison of Different Vaginal Self-sampling Devices and Urine for Human Papillomavirus Testing-Predictors 5.1.
Cancer Epidemiol Biomarkers Prev
; 30(4): 661-668, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33514604
5.
Human marginal zone B cell development from early T2 progenitors.
J Exp Med
; 218(4)2021 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538776
6.
Evaluation of Dried Blood Spots and Oral Fluids as Alternatives to Serum for Human Papillomavirus Antibody Surveillance.
mSphere
; 3(3)2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29743199
7.
Performance and Diagnostic Accuracy of a Urine-Based Human Papillomavirus Assay in a Referral Population.
Cancer Epidemiol Biomarkers Prev
; 26(7): 1053-1059, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28223432
8.
A comparison of different human papillomavirus tests in PreservCyt versus SurePath in a referral population-PREDICTORS 4.
J Clin Virol
; 82: 145-151, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27498250
9.
A randomized controlled trial in non-responders from Newcastle upon Tyne invited to return a self-sample for Human Papillomavirus testing versus repeat invitation for cervical screening.
J Med Screen
; 22(1): 28-37, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25403717
10.
Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions.
J Clin Virol
; 60(1): 44-9, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24630483